| VBID RFI final | |
| Track and Trace Comment Letter final | |
| Sebelius Essential Health Benefits Letter Jan 2011 | |
| REMS draft guidance comments 5.31.11 | |
| RAC RFI Comment Letter final | |
| PCMA Reinsurance risk corridors comments 10.31 | |
| PCMA Orphan Drug Comments | |
| PCMA IOM Essential Benefits Letter 1.28.11 | |
| PCMA IFR MLR Letter 1.31.11 | |
| PCMA DUR Comments 10.31.11 | |
| PCMA Comment Letter CMS 4157 P 2013 Part D Rule | |
| PCMA Comment Summary of Benefits and Coverage and Uniform Glossary 10.21 | |
| PCMA 2012 Part D Call Letter Comments | |
| PCMA PDUFA Public Mtg Comments 10.24.11 | |
| Medicare Data Performance Comments | |
| Final PCMA Sebelius Medicaid 2.25.11 | |
| FDA biosimlar user fee comments | |
| DIR 2010 comments | |
| Comments to proposed rule for CY 2012 | |
| CMS Classes of Clinical Concern Score Jan 09 | |
| Clinical Classes Raise Costs | |
| Appeals Amendment comments | |
